diethylstilbestrol has been researched along with buserelin in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (81.82) | 18.7374 |
1990's | 6 (18.18) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arkell, DG; Blackledge, GR; Dunn, JA; Emtage, LA; Lynch, TH; Wallace, DM; Waymont, B | 1 |
al-Bussam, N; Citrin, DL; Gau, TC; Guinan, P; Kennealey, GT; Resnick, MI; Scott, M | 1 |
Kuhn, JM | 1 |
Blackledge, GR; Boughton, BJ; Emtage, LA; George, J; Trethowan, C | 1 |
Moffat, LE | 1 |
Elder, JS; Gibbons, RP | 1 |
Blackledge, GR; Emtage, LA; Lewis, PW | 1 |
Peeling, WB | 1 |
Arkell, D; Blacklock, R; Emtage, LA; Hay, A; Hughes, M; Jones, M; Kelly, K; Rouse, A; Trethowan, C; Wallace, DM | 1 |
Griffiths, K; Turkes, AO | 1 |
Eisenberger, MA; Friedman, MA; O'Dwyer, PJ | 1 |
Bouffioux, C; de Leval, J; Denis, L; Mahler, C | 1 |
Opsomer, RJ; Van Cangh, PJ | 1 |
Debruyne, FM | 1 |
Debruyne, FM; Fernandez del Moral, P; Litjens, TT; Weil, EH | 1 |
Ahmann, FR; de Haan, H; Jordan, VC; Kreis, W; Scott, M | 1 |
Denis, L; Mahler, C | 1 |
Blackledge, GR; Emtage, LA; Hilton, C; Kelly, K; Trethowan, C | 1 |
Catt, KJ; Huhtaniemi, IT; Warren, DW | 1 |
Fiet, J; Moguilewsky, M; Raynaud, JP; Tournemine, C | 1 |
Hickey, D; Soloway, MS; Todd, B | 1 |
Belanger, A; Borsanyi, JP; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y; Monfette, G | 1 |
Soloway, MS | 1 |
Huben, RP; Murphy, GP | 1 |
Klioze, SS; Miller, MF; Spiro, TP | 1 |
Griffiths, K; Harper, ME; Peeling, WB; Pierrepoint, CG; Turkes, AO; Walker, KJ; Wilson, DW | 1 |
Paulson, DF | 1 |
Ford, KS; Kennedy, PS; Klioze, SS; Kosola, JW; Mendez, RG; Naessig, VL; Presant, CA; Soloway, MS; Wyres, MR; Yakabow, AL | 1 |
Matsuyama, A; Minaguchi, H; Namiki, T; Shirasu, K; Uemura, T | 1 |
Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
Catt, KJ; Huhtaniemi, IT; Warren, DD | 1 |
Wang, C | 1 |
Arakawa, S; Mori, H; Morita, T; Ohkawa, T; Okinaga, S; Takada, S; Yago, N | 1 |
3 review(s) available for diethylstilbestrol and buserelin
Article | Year |
---|---|
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Endocrine factors in the treatment of prostatic cancer.
Topics: Buserelin; Castration; Chorionic Gonadotropin; Cosyntropin; Dexamethasone; Diethylstilbestrol; Estrogens; Goserelin; Hormones; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1985 |
15 trial(s) available for diethylstilbestrol and buserelin
Article | Year |
---|---|
Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Diethylstilbestrol; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Time Factors; Treatment Outcome | 1992 |
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trial.
Topics: Aged; Antineoplastic Agents; Buserelin; Diethylstilbestrol; Drug Implants; Follow-Up Studies; Goserelin; Humans; Male; Prostatic Neoplasms | 1991 |
Haemostatic changes during hormone manipulation in advanced prostate cancer: a comparison of DES 3 mg/day and goserelin 3.6 mg/month.
Topics: Aged; Aged, 80 and over; Antithrombin III; Buserelin; Diethylstilbestrol; Goserelin; Hemostasis; Humans; Male; Middle Aged; Prostatic Neoplasms | 1990 |
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |
The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Antigens, Neoplasm; Biomarkers, Tumor; Bone Neoplasms; Buserelin; Diethylstilbestrol; Goserelin; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Random Allocation | 1987 |
Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Random Allocation; United Kingdom | 1989 |
A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Topics: Aged; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Diethylstilbestrol; Goserelin; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms; Random Allocation; United Kingdom | 1989 |
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
Topics: Buserelin; Delayed-Action Preparations; Diethylstilbestrol; England; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Efficacy of buserelin in advanced prostate cancer and comparison with historical controls.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Humans; Male; Orchiectomy; Prognosis; Prostatic Neoplasms; Time Factors | 1988 |
A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Diethylstilbestrol; Humans; Male; Methotrexate; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms | 1988 |
A randomized, comparative study of buserelin with DES/orchiectomy in the treatment of stage D2 prostatic cancer patients.
Topics: Administration, Intranasal; Administration, Oral; Buserelin; Diethylstilbestrol; Humans; Injections, Subcutaneous; Male; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Orchiectomy; Prognosis; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
17 other study(ies) available for diethylstilbestrol and buserelin
Article | Year |
---|---|
[Hormonal treatments of prostate cancer].
Topics: Androgen Antagonists; Buserelin; Carcinoma; Diethylstilbestrol; Drug Therapy, Combination; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms | 1990 |
Advances in the treatment of metastatic prostatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Male; Neoplasm Metastasis; Orchiectomy; Palliative Care; Prostatic Neoplasms | 1985 |
[Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Diethylstilbestrol; Goserelin; Humans; Male; Prostatic Neoplasms | 1986 |
Treatment of advanced carcinoma of the prostate with a depot luteinizing hormone-releasing hormone analogue (ICI-118630).
Topics: Aged; Buserelin; Carcinoma; Delayed-Action Preparations; Diethylstilbestrol; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1987 |
Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?
Topics: Aged; Buserelin; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1988 |
Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.
Topics: Buserelin; Diethylstilbestrol; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1988 |
Simultaneous administration of a luteinizing hormone releasing hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Testosterone | 1988 |
Regulation of infant and developing rat testicular gonadotropin and prolactin receptors and steroidogenesis by treatments with human chorionic gonadotropin, gonadotropin-releasing hormone analogs, bromocriptine, prolactin, and estrogen.
Topics: Animals; Animals, Newborn; Bromocriptine; Buserelin; Chorionic Gonadotropin; Diethylstilbestrol; Hormones; Leydig Cells; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Receptors, Prolactin; Testis; Testosterone | 1985 |
Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.
Topics: Androgen Antagonists; Animals; Buserelin; Diethylstilbestrol; Humans; Imidazoles; Imidazolidines; Kinetics; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Cell Surface; Receptors, LHRH; Receptors, Steroid; Testosterone | 1986 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Management of metastatic prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Castration; Cyclophosphamide; Diethylstilbestrol; Estramustine; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1985 |
Buserelin as primary therapy in advanced prostatic carcinoma.
Topics: Adult; Aged; Buserelin; Castration; Diethylstilbestrol; Humans; Male; Middle Aged; Pain; Prostatic Neoplasms; Quality of Life; Testosterone | 1985 |
Increases in ovarian GnRH receptors by following GnRH treatment.
Topics: Animals; Buserelin; Diethylstilbestrol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Equine; Hypophysectomy; Kinetics; Ovary; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LHRH; Sexual Maturation | 1984 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Comparison of oestrogen and GnRH agonist analogue-induced inhibition of the pituitary-testicular function in rat.
Topics: Animals; Buserelin; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Organ Size; Pituitary Gland; Prolactin; Prostate; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Receptors, Peptide; Seminal Vesicles; Testis | 1983 |
Luteinizing hormone releasing hormone stimulates plasminogen activator production by rat granulosa cells.
Topics: Animals; Buserelin; Diethylstilbestrol; Female; Fibrin; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cells; Plasminogen Activators; Rats; Rats, Inbred Strains | 1983 |
Effects of gonadotropin-releasing hormone agonist on steroidogenesis in the rat ovary.
Topics: Animals; Aromatase; Buserelin; Cells, Cultured; Chorionic Gonadotropin; Diethylstilbestrol; Estradiol; Female; Follicle Stimulating Hormone; Hypophysectomy; Kinetics; Ovary; Progesterone; Rats; Rats, Wistar; Receptors, LHRH | 1994 |